Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Brands Regulatory News (IMB)

Share Price Information for Imperial Brands (IMB)

Share Price is delayed by 15 minutes
Get Live Data
2,787.00    -16.00 (-0.57%)
Bid:
2,795.00
Ask:
2,797.00
Spread: 2.00 (0.072%)
Market Cap: £21.44b
IMB Live PriceLast checked at - London Stock Exchange

Intraday Imperial Brands Share Chart

Directorate change

20 Jan 2026 07:00

RNS Number : 5122P
Imperial Brands PLC
20 January 2026
 

 

 

IMPERIAL BRANDS PLC

 

Legal Entity Identifier (LEI) No. 549300DFVPOB67JL3A42

 

20 January 2026

APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND CHAIR DESIGNATE

Imperial Brands PLC is pleased to announce the appointment of John Rishton as a Non-Executive Director and Chair Designate following a comprehensive search process.

 

John will join the Board as Non-Executive Director and Chair Designate on 13 July 2026. He will succeed Thérèse Esperdy as Chair on 1 December 2026, at which time Thérèse will retire from the Board.

 

Thérèse was appointed to the Imperial Brands Board in July 2016 and became Senior Independent Director in May 2019 before being appointed Chair in January 2020.

 

John is currently chair of Informa PLC and a non-executive director of Diageo PLC, with significant board and executive leadership experience across diverse industries and a reputation for guiding complex transformations. He served as chair of Serco Group PLC between 2021 and 2025 and was a non-executive director of Unilever PLC and Allied Domecq PLC. John's previous executive positions include chief executive of Rolls-Royce Group PLC from 2011 to 2015 (having been a non-executive director since 2007), chief financial officer and then chief executive and president of Royal Ahold NV and chief financial officer of British Airways PLC.

 

The appointment was approved by the Board and follows a thorough succession process undertaken by the People, Governance & Sustainability (PGS) Committee, led by Sue Clark, the company's Senior Independent Director, in which all the Non-Executive Directors participated. 

 

Sue Clark said: "The Board is delighted to appoint an exceptional candidate as Chair. John has impressive experience of senior non-executive roles and complex, highly regulated, international businesses. His deep understanding of transformation and sectors experiencing strategic shifts will be invaluable as he leads the Imperial Brands Board.

 

"On behalf of the Board, I would like to thank Thérèse for her outstanding contribution over the past decade. She has been pivotal in making Imperial Brands the strong, challenger business it is today. Thérèse will remain as Chair until 1 December to facilitate an orderly succession to John."

 

John Rishton said: "It is a great honour to have been asked to succeed Thérèse as Chair of Imperial Brands. I look forward to working with the Board and with Lukas and his leadership team to support the delivery of the company's ambitious strategic objectives."

 

Lukas Paravicini, Imperial Brands CEO, said: "I speak for everyone at Imperial Brands in thanking Thérèse for her leadership as Chair. Under Thérèse's stewardship, Imperial Brands has turned around its core tobacco business, developed a growing portfolio of next generation products and delivered more than £10 billion in capital returns to shareholders.

 

"Our business is well positioned for the future, and I look forward to working with John and the Board as we focus on implementing our evolved strategy and continuing to drive consistent sustainable growth."

 

There are no other matters that require disclosure under UKLR 6.4.8 of the UK Listing Rules sourcebook.

 

 

Notes to editors

 

John Rishton is an experienced Chair and leader, with a breadth of experience across a broad range of sectors from travel, retail, consumer products and media to automotive and engineering. He is chair of Informa PLC (appointed in 2016) and recently retired as chair of Serco Group PLC. John is a non-executive director at Diageo PLC, where he is a member of their audit and nomination committees. He was previously a non-executive director at Unilever PLC, Allied Domecq PLC and Rolls-Royce Group PLC.

 

John has enjoyed a distinguished Executive career, having previously been CFO at British Airways PLC, CFO and CEO of Royal Ahold NV and CEO of Rolls Royce.

 

Thérèse Esperdy joined the Board in 2016, becoming Chair in 2020. Under the UK Corporate Governance Code, she reached the "comply or explain" nine-year tenure point from her date of appointment to the Board in 2025. Following consultation with shareholders, Executives and advisers, the PGS Committee, led by the Senior Independent Director, Sue Clark, recommended to the Board that Thérèse's tenure as Chair be extended to provide continuity whilst Lukas Paravicini and Murray McGowan establish themselves in their new roles as CEO and CFO respectively.

 

ENDS

 

 

Investor Contacts

Media Contacts

John Crosse

+44 (0)7484 967842

Jonathan Oliver

+44 (0)7740 096 018

Jennifer Ramsey

+44 (0)7974 615 739

Simon Evans

+44 (0)7967 467 684

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGMMMLGGVZZ
Date   Source Headline
10th Jun 20265:38 pmRNSTransaction in Own Shares
10th Jun 20269:41 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20265:33 pmRNSTransaction in Own Shares
3rd Jun 20265:35 pmRNSTransaction in Own Shares
2nd Jun 20265:27 pmRNSTransaction in Own Shares
1st Jun 20265:29 pmRNSTransaction in Own Shares
1st Jun 202610:09 amRNSTotal Voting Rights
29th May 20265:32 pmRNSTransaction in Own Shares
28th May 20265:29 pmRNSTransaction in Own Shares
28th May 20269:15 amRNSTransaction in Own Shares
27th May 202612:01 pmRNSAcquisition of Black Buffalo
26th May 20265:53 pmRNSTransaction in Own Shares
22nd May 20265:26 pmRNSTransaction in Own Shares
21st May 20265:28 pmRNSTransaction in Own Shares
20th May 20265:33 pmRNSTransaction in Own Shares
19th May 20265:25 pmRNSTransaction in Own Shares
18th May 20265:23 pmRNSTransaction in Own Shares
15th May 20265:25 pmRNSTransaction in Own Shares
14th May 20265:20 pmRNSTransaction in Own Shares
14th May 20269:20 amRNSTransaction in Own Shares
12th May 20265:37 pmRNSTransaction in Own Shares
12th May 20267:04 amRNSDividend Declaration
12th May 20267:00 amRNSHalf-year Financial Report
11th May 20265:22 pmRNSTransaction in Own Shares
8th May 20265:43 pmRNSTransaction in Own Shares
7th May 20265:30 pmRNSTransaction in Own Shares
6th May 20265:16 pmRNSTransaction in Own Shares
5th May 20265:28 pmRNSTransaction in Own Shares
1st May 20265:30 pmRNSTransaction in Own Shares
1st May 20263:31 pmRNSTotal Voting Rights
30th Apr 20265:37 pmRNSTransaction in Own Shares
29th Apr 20265:13 pmRNSTransaction in Own Shares
28th Apr 20265:29 pmRNSTransaction in Own Shares
27th Apr 20265:30 pmRNSTransaction in Own Shares
24th Apr 20265:37 pmRNSTransaction in Own Shares
23rd Apr 20265:40 pmRNSTransaction in Own Shares
23rd Apr 20265:28 pmRNSHolding(s) in Company
23rd Apr 20269:57 amRNSTransaction in Own Shares
21st Apr 20265:24 pmRNSTransaction in Own Shares
20th Apr 20265:37 pmRNSTransaction in Own Shares
17th Apr 20266:05 pmRNSTransaction in Own Shares
16th Apr 20265:32 pmRNSTransaction in Own Shares
15th Apr 20265:24 pmRNSTransaction in Own Shares
15th Apr 20264:44 pmRNSDirector Declaration
14th Apr 20265:41 pmRNSTransaction in Own Shares
14th Apr 202612:28 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTrading Update
13th Apr 20265:53 pmRNSTransaction in Own Shares
13th Apr 20265:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.